investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
A novel approach into modeling origin and development of ovarian cancer
Alicia S Kunin-Batson
2 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Daniel W Cramer
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
Ovary
Pathology
Shelley S Tworoger
Psychological Stress, Associate Biologic Mediators, and Ovarian Cancer Risk
Ovary
Pathology
Tsz-Kwong Man
Harnessing p27 for Prognostication of Pediatric Osteosarcoma
Ovary
Pediatric oncology or childhood cancer
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology
Frederick Appelbaum
Cancer Center Support Grant (Comprehensive)
Ovary
Scott H Kaufmann
Mayo Clinic SPORE in Ovarian Cancer
Ovary
Pathology
Mary Anne Rossing
Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer
Ovary
Pathology
Linda S Cook
Mitochondrial DNA and Ovarian Cancer Risk and Survival
Ovary
Pathology
Lesley M Butler
Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort
Ovary
Pathology